Bacil Pharma P/B Ratio
Bacil Pharma (BACPHAR) P/B ratio is 1.05 (Moderate), book value per share ₹17.86 vs Healthcare average P/B of -0.01 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see BACPHAR stock price BSE.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
BACPHAR P/B Ratio — Valuation Insights & Book Value Analysis
Bacil Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 1.05 (Moderate). Read Bacil Pharma dividend policy for the complete payout history and dividend yield track record.
- Current PB is 90.0% below historical average
- Trading at premium to sector average PB of -0.01
Bacil Pharma P/B Ratio Historical Trend
BACPHAR annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Explore BACPHAR Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.
BACPHAR Historical P/B Ratio — Book Value Per Share & Year-End Price
Bacil Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.2 | ₹17.86 | ₹21.44 | ₹25 | Moderate |
| 2025 | 2.0 | ₹17.86 | ₹35.64 | ₹25 | Moderate |
| 2024 | 38.04 | ₹1.43 | ₹54.34 | ₹1 | High |
| 2023 | 4.47 | ₹1.43 | ₹6.38 | ₹1 | High |
| 2022 | 6.58 | ₹1.43 | ₹9.40 | ₹1 | High |
BACPHAR vs Healthcare Peers — P/B Ratio Comparison
Bacil Pharma P/B 1.05 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |